Merck (MRK) Gross Profit Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.44% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
9.77% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
15.45% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-0.16% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
13.38% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
7.57% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-65.16% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-1.22% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-0.16% |
| Dec 31, 2025 |
-8.03% |
| Sep 30, 2025 |
6.71% |
| Jun 30, 2025 |
-0.95% |
| Mar 31, 2025 |
-1.02% |
| Dec 31, 2024 |
10.06% |
| Sep 30, 2024 |
7.51% |
| Jun 30, 2024 |
12.31% |
| Mar 31, 2024 |
15.85% |
| Dec 31, 2023 |
7.73% |
| Sep 30, 2023 |
6.10% |
| Jun 30, 2023 |
6.11% |
| Mar 31, 2023 |
0.38% |
| Dec 31, 2022 |
3.13% |
| Sep 30, 2022 |
13.61% |
| Jun 30, 2022 |
25.05% |
| Mar 31, 2022 |
41.64% |
| Dec 31, 2021 |
62.98% |
| Sep 30, 2021 |
22.59% |
| Jun 30, 2021 |
25.61% |
| Mar 31, 2021 |
-15.06% |
| Dec 31, 2020 |
129.77% |
| Sep 30, 2020 |
-5.84% |
| Jun 30, 2020 |
-20.97% |
| Mar 31, 2020 |
12.64% |
| Dec 31, 2019 |
-66.58% |
| Sep 30, 2019 |
17.17% |
| Jun 30, 2019 |
18.60% |
| Mar 31, 2019 |
13.29% |
| Dec 31, 2018 |
10.24% |
| Sep 30, 2018 |
2.24% |
| Jun 30, 2018 |
3.43% |
| Mar 31, 2018 |
7.33% |
| Dec 31, 2017 |
5.25% |
| Sep 30, 2017 |
-1.53% |
| Jun 30, 2017 |
8.75% |
| Mar 31, 2017 |
11.24% |
| Dec 31, 2016 |
4.38% |
| Sep 30, 2016 |
12.91% |
| Jun 30, 2016 |
3.90% |
| Mar 31, 2016 |
-1.98% |
| Dec 31, 2015 |
-5.47% |
| Sep 30, 2015 |
-0.35% |
| Jun 30, 2015 |
-0.17% |
| Mar 31, 2015 |
-7.94% |
| Dec 31, 2014 |
0.30% |
| Sep 30, 2014 |
-8.57% |
| Jun 30, 2014 |
-10.18% |
| Mar 31, 2014 |
-5.23% |
| Dec 31, 2013 |
-11.40% |
| Sep 30, 2013 |
-5.75% |
| Jun 30, 2013 |
-17.97% |
| Mar 31, 2013 |
-12.76% |
| Dec 31, 2012 |
-6.66% |
| Sep 30, 2012 |
-4.16% |
| Jun 30, 2012 |
4.22% |
| Mar 31, 2012 |
2.30% |
| Dec 31, 2011 |
6.06% |
| Sep 30, 2011 |
10.61% |
| Jun 30, 2011 |
15.74% |
| Mar 31, 2011 |
21.19% |
| Dec 31, 2010 |
47.41% |
| Sep 30, 2010 |
50.11% |
| Jun 30, 2010 |
49.52% |
| Mar 31, 2010 |
53.18% |
